These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 25588253)

  • 21. The action of the sodium ionophore, monensin, or transmitter release at the frog neuromuscular junction.
    Meiri H; Erulkar SD; Lerman T; Rahamimoff R
    Brain Res; 1981 Jan; 204(1):204-8. PubMed ID: 6113873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of neuromuscular block by streptomycin: a voltage clamp analysis.
    Farley JM; Wu CH; Narahashi T
    J Pharmacol Exp Ther; 1982 Aug; 222(2):488-93. PubMed ID: 6980271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions.
    Bukcharaeva EA; Kim KC; Moravec J; Nikolsky EE; Vyskocil F
    J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):879-88. PubMed ID: 10358126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction.
    Tsentsevitsky A; Kovyazina I; Nikolsky E; Bukharaeva E; Giniatullin R
    Neuroscience; 2013 Sep; 248():699-707. PubMed ID: 23806718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenosine effects upon transmitter release parameters in the Mg2+-paralyzed neuro-muscular junction of frog.
    Brănişteanu DD; Haulică ID; Proca B; Nhue BG
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Sep; 308(3):273-9. PubMed ID: 41193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action potentials must admit calcium to evoke transmitter release.
    Mulkey RM; Zucker RS
    Nature; 1991 Mar; 350(6314):153-5. PubMed ID: 1672444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a reduction in temperature on the quantal release of transmitter at the mouse neuromuscular junction.
    Nishimura M; Shimizu Y; Satoh E; Yokoyama T; Yagasaki O
    Gen Pharmacol; 1993 Sep; 24(5):1235-9. PubMed ID: 7903651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of streptomycin on the neuromuscular junction of the frog.
    Tamaki M
    Brain Res; 1983 Apr; 265(2):241-7. PubMed ID: 6850327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmitter release in ouabain treated Mg(2+)--paralysed neuromuscular junctions.
    Brănişteanu DD; Proca B; Zaim R; Brănişteanu G; Volle RL
    Rev Med Chir Soc Med Nat Iasi; 1978; 82(3):437-47. PubMed ID: 16296503
    [No Abstract]   [Full Text] [Related]  

  • 31. [Regulation of tetanus toxin-inhibited transmitter secretion in the neuromuscular junction in a calcium-free medium].
    Kryzhanovskiĭ GN; Polgar AA; Smirnova VS; Zinkevich VA
    Biull Eksp Biol Med; 1985 Apr; 99(4):407-9. PubMed ID: 2859057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of the kinetics of evoked quantal release at mouse neuromuscular junctions by calcium and strontium.
    Bukharaeva EA; Samigullin D; Nikolsky EE; Magazanik LG
    J Neurochem; 2007 Feb; 100(4):939-49. PubMed ID: 17212698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the aminoglycoside antibiotics, streptomycin and neomycin, on neuromuscular transmission. II. Postsynaptic considerations.
    Fiekers JF
    J Pharmacol Exp Ther; 1983 Jun; 225(3):496-502. PubMed ID: 6306208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of calcium ions on bimodal parameters of mediator liberation in frog sartorius muscle neuromuscular junctions].
    Zefirov AL
    Fiziol Zh SSSR Im I M Sechenova; 1980 Apr; 66(4):531-6. PubMed ID: 6104608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between temperature and calcium ion concentration in the medium and the effect of imidazole, guanidine and theophylline on mediator release at the frog neuromuscular synapse].
    Gotgil'f IM
    Neirofiziologiia; 1977; 9(4):430-6. PubMed ID: 302923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive antagonism between calcium and antibiotics at the neuromuscular junction.
    Prado WA; Corrado AP; Marseillan RF
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):297-307. PubMed ID: 646525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spontaneous and evoked quantal neurotransmitter release at the neuromuscular junction of the larval housefly, Musca domestica.
    Seabrook GR; Duce IR; Irving SN
    Pflugers Arch; 1989 May; 414(1):44-51. PubMed ID: 2566966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression of spontaneous and ionophore-induced transmitter release by ruthenium red at the neuromuscular junction.
    Person RJ; Kuhn JA
    Brain Res Bull; 1979; 4(5):669-74. PubMed ID: 487223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presynaptic M(2) muscarinic receptors are involved in controlling the kinetics of ACh release at the frog neuromuscular junction.
    Slutsky I; Silman I; Parnas I; Parnas H
    J Physiol; 2001 Nov; 536(Pt 3):717-25. PubMed ID: 11691867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual effect of 2,4-dinitrophenol on the spontaneous release of transmitter at the frog neuromuscular junction.
    Statham HE; Duncan CJ; Publicover SJ
    Biochem Pharmacol; 1978; 27(18):2199-202. PubMed ID: 31881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.